MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.880
+0.050 (1.77%)
Sep 9, 2024, 4:00 PM EDT - Market closed

MDxHealth Statistics

Total Valuation

MDxHealth has a market cap or net worth of $78.59 million. The enterprise value is $113.91 million.

Market Cap 78.59M
Enterprise Value 113.91M

Important Dates

The last earnings date was Wednesday, August 21, 2024, after market close.

Earnings Date Aug 21, 2024
Ex-Dividend Date n/a

Share Statistics

MDxHealth has 27.29 million shares outstanding. The number of shares has increased by 32.87% in one year.

Shares Outstanding 27.29M
Shares Change (YoY) +32.87%
Shares Change (QoQ) -0.03%
Owned by Insiders (%) 8.25%
Owned by Institutions (%) 5.55%
Float 15.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.98
Forward PS 0.89
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.41
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.91

Current Ratio 0.91
Quick Ratio 0.77
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.96

Financial Efficiency

Return on equity (ROE) is -457.29% and return on invested capital (ROIC) is -26.13%.

Return on Equity (ROE) -457.29%
Return on Assets (ROA) -11.00%
Return on Capital (ROIC) -26.13%
Revenue Per Employee $269,137
Profits Per Employee -$136,013
Employee Count 300
Asset Turnover 0.59
Inventory Turnover 9.39

Taxes

In the past 12 months, MDxHealth has paid $1,000 in taxes.

Income Tax 1,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.88% in the last 52 weeks. The beta is -396,386.55, so MDxHealth's price volatility has been lower than the market average.

Beta (5Y) -396,386.55
52-Week Price Change -5.88%
50-Day Moving Average 2.77
200-Day Moving Average 3.06
Relative Strength Index (RSI) 50.71
Average Volume (20 Days) 39,747

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MDxHealth had revenue of $80.74 million and -$40.80 million in losses. Loss per share was -$1.49.

Revenue 80.74M
Gross Profit 50.57M
Operating Income -24.06M
Pretax Income -39.90M
Net Income -40.80M
EBITDA -18.62M
EBIT -24.06M
Loss Per Share -$1.49
Full Income Statement

Balance Sheet

The company has $21.34 million in cash and $56.66 million in debt, giving a net cash position of -$35.32 million or -$1.29 per share.

Cash & Cash Equivalents 21.34M
Total Debt 56.66M
Net Cash -35.32M
Net Cash Per Share -$1.29
Equity (Book Value) -8.81M
Book Value Per Share -0.32
Working Capital -4.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.43 million and capital expenditures -$1.38 million, giving a free cash flow of -$22.81 million.

Operating Cash Flow -21.43M
Capital Expenditures -1.38M
Free Cash Flow -22.81M
FCF Per Share -$0.84
Full Cash Flow Statement

Margins

Gross margin is 62.64%, with operating and profit margins of -29.80% and -50.54%.

Gross Margin 62.64%
Operating Margin -29.80%
Pretax Margin -50.54%
Profit Margin -50.54%
EBITDA Margin -23.06%
EBIT Margin -29.80%
FCF Margin -33.09%

Dividends & Yields

MDxHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -32.87%
Shareholder Yield -32.87%
Earnings Yield -51.92%
FCF Yield -29.02%

Analyst Forecast

The average price target for MDxHealth is $7.50, which is 160.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 160.42%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 17.34%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date Nov 14, 2023
Split Type Reverse
Split Ratio 0.1:1

Scores

MDxHealth has an Altman Z-Score of -3.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.42
Piotroski F-Score 3